Nitrocine (Glyceryl Trinitrate)

Glyceryl Trinitrate, the active ingredient in Nitrocine, is an organic nitrate vasodilator presented as an injection solution for intravenous use. It is employed to relieve acute angina, support management of myocardial infarction, and lower blood pressure in hypertensive emergencies.

GNH USA supplies Nitrocine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to EU quality standards and provides regulatory‑approved batches to healthcare facilities across multiple regions.

Nitrocine, an organic nitrate vasodilator, is used in several acute cardiovascular conditions where rapid reduction of myocardial oxygen demand is required.

Acute angina pectoris: provides rapid relief of chest pain by dilating coronary vessels. Myocardial infarction (adjunct therapy): reduces cardiac workload during acute coronary events. Acute decompensated heart failure: improves hemodynamics by decreasing preload and afterload. Hypertensive emergencies: lowers systemic vascular resistance to control severe blood pressure spikes.

Intravenous administration of Nitrocine may be associated with a range of adverse reactions.

Common Side Effects: - Headache: throbbing pain due to cerebral vasodilation. - Flushing: warmth and redness of the skin. - Hypotension: transient drop in blood pressure. - Tachycardia: compensatory increase in heart rate. - Dizziness: light‑headed sensation.

Serious or Rare Side Effects: - Severe hypotension: marked blood pressure fall leading to syncope. - Methemoglobinemia: rare oxidation of hemoglobin impairing oxygen delivery. - Allergic reaction: rash, itching, or anaphylaxis. - Cardiac arrest: extremely rare but life‑threatening event.

When using Nitrocine, clinicians should observe several safety measures to minimise risks. - Blood pressure monitoring: check systolic and diastolic values before and during infusion. - Dose titration: adjust infusion rate gradually to avoid abrupt hypotension. - Concurrent nitrate therapy: avoid co‑administration to prevent additive vasodilation. - Cardiovascular status: use cautiously in patients with severe aortic stenosis or recent myocardial infarction. - Pregnancy and lactation: assess risk‑benefit as safety data are limited. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Nitroglycerin interacts with several drug classes that can modify its hemodynamic effects.

Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): may cause profound hypotension. - Other vasodilators (e.g., hydralazine): additive blood pressure lowering. - Sodium nitroprusside: excessive nitrate load leading to methemoglobinemia.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt reflex tachycardia. - Diuretics: can enhance hypotensive response. - ACE inhibitors or ARBs: may increase risk of low blood pressure.